Arylindenopyrimidines and their use as Adenosine A2a receptor antagonists

Details for Australian Patent Application No. 2008317034 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Jackson, Paul F.; Shook, Brian C.

Agent Shelston IP

Pub. Number AU-A-2008317034

PCT Pub. Number WO2009/055308

Priority 60/982,247 24.10.07 US

Filing date 17 October 2008

Wipo publication date 30 April 2009

International Classifications

C07D 239/70 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/055308 Priority application(s): WO2009/055308

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008317037-Safety sealed reservoir cap

2008317024-Pressure sensing intragastric balloon